,trastuzumab deruxtecan
astrazeneca,daiichi sankyo
['tnbc', 'bcsm', 'breast', 'destiny-breast04']
2/ still it's uplifting to see survival benefit for hr- disease esp tnbc which needs more therapeutic options. destiny-breast04 #asco22 #bcsm 
Mother of Warlords & Slayer of Cancers|Brst/Gyn #radonc @WeillCornell @nyphospital @nypbrooklyn | #globaloncology | #globalhealth|#MedEd|#gyncsm|#bcsm????????